BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8196191)

  • 1. [Signal transduction of the thyrotropin receptor].
    Kosugi S; Mori T
    Nihon Rinsho; 1994 Apr; 52(4):984-9. PubMed ID: 8196191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
    Kosugi S; Kohn LD; Akamizu T; Mori T
    Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The amino-terminal half of the cytoplasmic tail of the thyrotropin receptor is essential for full activities of receptor function.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1994 Apr; 200(1):401-7. PubMed ID: 8166712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases.
    Yano K; Hidaka A; Saji M; Polymeropoulos MH; Okuno A; Kohn LD; Cutler GB
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1818-23. PubMed ID: 7527413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty.
    Yano K; Saji M; Hidaka A; Moriya N; Okuno A; Kohn LD; Cutler GB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1162-8. PubMed ID: 7714085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor.
    Yano K; Kohn LD; Saji M; Okuno A; Cutler GB
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2586-91. PubMed ID: 9253338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of the thyrotropin receptor by mutating CYS-636 in the sixth transmembrane segment.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1996 May; 222(3):713-7. PubMed ID: 8651910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A; Minegishi T; Kohn LD
    Biochem Biophys Res Commun; 1993 Oct; 196(1):187-95. PubMed ID: 8216292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.
    Wonerow P; Neumann S; Gudermann T; Paschke R
    J Mol Med (Berl); 2001 Dec; 79(12):707-21. PubMed ID: 11862314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the extracellular domain and the extracellular loops as well as the 6th transmembrane domain are necessary for TSH receptor activation.
    Neumann S; Claus M; Paschke R
    Eur J Endocrinol; 2005 Apr; 152(4):625-34. PubMed ID: 15817920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
    Kosugi S; Mori T
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1497-503. PubMed ID: 8147896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S; Krohn K; Chey S; Paschke R
    Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Constitutively activating mutations in the luteinizing hormone receptor gene in cases of male-limited precocious puberty].
    Yano K; Okuno A
    Nihon Rinsho; 1998 Jul; 56(7):1843-7. PubMed ID: 9702063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first cytoplasmic loop of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation.
    Kosugi S; Mori T
    FEBS Lett; 1994 Mar; 341(2-3):162-6. PubMed ID: 8137933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.
    Parma J; Duprez L; Van Sande J; Cochaux P; Gervy C; Mockel J; Dumont J; Vassart G
    Nature; 1993 Oct; 365(6447):649-51. PubMed ID: 8413627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial male-limited precocious puberty].
    Katsumata N; Tanaka T
    Nihon Rinsho; 1997 Nov; 55(11):2959-62. PubMed ID: 9396295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The third exoplasmic loop of the thyrotropin receptor is partially involved in signal transduction.
    Kosugi S; Mori T
    FEBS Lett; 1994 Jul; 349(1):89-92. PubMed ID: 8045308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
    Zhang ML; Sugawa H; Kosugi S; Mori T
    Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor.
    Kosugi S; Mori T; Shenker A
    Mol Pharmacol; 1998 May; 53(5):894-901. PubMed ID: 9584216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of association between activated Galpha q and Gbetagamma disrupts receptor-dependent and receptor-independent signaling.
    Evanko DS; Thiyagarajan MM; Takida S; Wedegaertner PB
    Cell Signal; 2005 Oct; 17(10):1218-28. PubMed ID: 16038796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.